Research & Clinical trials
A tech-enabled adherence solution designed for patients and study teams
Our flexible, asynchronous, video technology & review service allows for dose-by-dose insights to help sponsors and CROs accelerate trials.
A tech-enabled adherence solution designed for patients and study teams
Our flexible, asynchronous, video technology & review service allows for dose-by-dose insights to help sponsors and CROs accelerate trials.
With asynchronous video technology and service, every dose is directly observed, improving data accuracy and adherence. Real-time data ensures compliance is tracked earlier and more effectively, helping teams take corrective action when needed. This results in better efficacy estimates and enhanced patient support.
Scene’s patient-centric design, low-tech requirements, and availability in multiple languages reduces barriers to trial participation. Early dose-by-dose identification of potential adherence issues enables rapid, patient-specific interventions that support each patient through their clinical study journey, reducing study dropout and, thus, improving retention.
Scene offers white-glove support to ensure smooth execution and high-quality data while speeding up trial completion. Our flexible approach accommodates various study protocols and administration methods—whether orals, inhalers, topicals, or injections. Scene delivers reliable, on-time, and cost-effective trial completion without adding an unnecessary burden on the sites.
Patients complete video check-ins of each dose, anytime and anywhere using our easy-to-use app. The Scene adherence team visually confirms that every dose of medication is ingested properly using our patented review portal. Scene’s adherence platform offers:
Scene's review, engagement, escalation is configured in a playbook, based on trial-specific protocols. Reviewers to assess videos and alert stakeholders to potential issues. This timely escalation and engagement helps ensure better patient adherence and engagement management.
Detailed patient, site, and population-level analytics are available on demand via configurable dashboards. Accurate dosing data lets sponsors and CROs know which patients are at risk of missing adherence targets and provides a view into which study sites need additional support enabling early interventions.
Our technology-enabled service is validated across diverse populations and indications, with publications reporting up to 98% adherence in underrepresented, high-cost patient groups in both clinical and real-world settings.